Outcomes of patients in clinical trials with ST-segment elevation myocardial infarction among countries with different gross national incomes

European Heart Journal

Volumn 27, Issue 5, 2006, Pages 527-533

  Orlandini, Andrés ^a   Díaz, Rafael ^a   Wojdyla, Daniel ^a   Pieper, Karen ^b   Van De Werf, Frans ^c   Granger, Christopher B ^b   Harrington, Robert A ^b   Boersma, Eric ^d   Califf, Robert M ^b   Armstrong, Paul ^e   White, Harvey ^f   Simes, John ^g   Paolasso, Ernesto ^a  

^a ECLA   (Argentina)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^d ERASMUS MEDICAL CENTER   (Netherlands)

^e UNIVERSITY OF ALBERTA   (Canada)

^f GREEN LANE HOSPITAL   (New Zealand)

^g UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Clinical trials; Gross national income; Outcomes; Regional differences; ST elevation myocardial infarction

Indexed keywords

ADULT; ARTICLE; FEMALE; HEALTH CARE COST; HEART INFARCTION; HOSPITAL MANAGEMENT; HUMAN; INCOME; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; ST SEGMENT ELEVATION;

FEMALE; FIBRINOLYTIC AGENTS; HOSPITALIZATION; HUMANS; INCOME; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; WORLD HEALTH;

EID: 33645228766     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehi701     Document Type: Article

References (26)

1. Fox KA, Goodman S, Bigonzi F, Le Louer V, Cohen M, the ESSENCE trial investigators. Inter-regional differences and outcome in unstable angina. Analysis of the international ESSENCE trial. Eur Heart J 2000;21:1433-1439.
2. Cohen M, Pacchiana C, Corbalan R, Isea Perez JE, Ponte C, Oropeza ES, Diaz R, Paolasso E, Izasa D, Rodas MA, Urritia C, Harrington R, Topol E, Califf R. Variation in patient management and outcomes for acute coronary syndromes in Latin America and North America. Results from the Platelet IIb/IIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy (PURSUIT) trial. Am Heart J 2001;41:391-401.
3. Yusuf S, Flather M, Pogue J, Hunt D, Varigos J, Piegas L, Avezum A, Anderson J, Keltai M, Budaj A, Fox K, Ceremuzynski L, for the OASIS (Organization Assess Strategies for lschaemic Syndromes) Registry Investigators. Variations between countries in invasive cardiac procedures and outcomes in patients with suspected unstable angina or myocardial infarction without initial ST elevation. Lancet 1998;352:507-514.
4. Windecker S, Meyer BJ, Bonzel T, Fabian J, Heyndrickx G, Morice MC, Mühlberger V, Piscione F, Rothman M, Wijns W, van den Brand M, Meier B, on behalf of the working group Coronary Circulation of the European Society of Cardiology. Interventional Cardiology in Europe 1994. Eur Heart J 1998;19:40-54.
5. Holmes DR, Califf RM, Van de Werf F, Berger PB, Bates ER, Simoons ML, White HD, Thompson TD, Topol EJ. Difference in countries' use of resources and clinical outcome for patients with cardiogenic shock after myocardial infarction. Results from the GUSTO trial. Lancet 1997;349:75-78.
6. Van de Werf F, Topol EJ, Lee KL, Woodlief LH, Granger C, Armstrong P, Barbash Gl, Hampton JR, Guerci A, Simes RJ, Ross AM, Califf RM, for the GUSTO Investigators. Variations in patient management and outcomes for acute myocardial infarction in the United States and other countries. Results from the GUSTO Trial. JAMA 1995;273:1586-1591.
7. O'Shea JC, Califf RM. Inter-regional differences in acute coronary syndrome trials. Eur Heart J 2000;21:1397-1399.
8. The GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 1993;329:673-682.
9. Fu Y, Ching CW, Mark D, Califf R, Mackenzie B, Granger C, Topol E, Hlatky M, Armstrong P, for the Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) IIb Investigators. Canadian-American differences in the management of acute coronary syndromes in the GUSTO IIb Trial. One year follow-up of patients without ST-segment elevation. Circulation 2000;102:1375-1381.
10. Shibata M, Flather M, Perez de Arenaza D, Wang D, O'Shea JC. Potential impact of socioeconomic differences on clinical outcomes in international clinical trials. Am Heart J 2001;1411:1019-1024.
11. Kramer JM, Newby LK, Ching CW, Simes J, Van de Werf F, Granger C, Lee K, White HD, Piegas LS, Topol EJ, Califf R, for the SYMPHONY and 2nd SYMPHONY investigators. International variation in the use of evidence-based medicines for acute coronary syndromes. Eur Heart J 2003;24:2133-2141.
12. Gupta M, Ching CW, Van de Werf F, Granger CB, Midodzi W, Barbash G, Pehrson K, Oto A, Toutouzas P, Jansky P, Armstrong PW, for the ASSENT II Investigators. International differences in in-hospital revascularization and outcomes following acute myocardial infarction. A multilevel analysis of patients in ASSENT-2. Eur Heart J 2003;24:1640-1650.
13. The Continuous Infusion Versus Double-Bolus Administration of Alteplase (COBALT) Investigators. A comparison of continuous infusion of alteplase with double-bolus administration for acute myocardial infarction. N Engl J Med 1997;337:1124-1130.
14. Assessment of the Safety and Efficacy of a New Thrombolytic (ASSENT-2) Investigators. Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial. Lancet 1999;354:716-722.
15. The Hirulog and Early Reperfusion or Occlusion (HERO)-2 Trial Investigators. Thrombin-specific anticoagulation with bivalirudin versus heparin in patients receiving fibrinolytic therapy for acute myocardial infarction: the HERO-2 randomised trial. Lancet 2001;358:1855-1863.
16. The Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 Trial Investigators. Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractioned heparin: the ASSENT-3 randomized trial in acute myocardial infarction. Lancet 2001;358:605-613.
17. Diaz R, Paolasso E, Piegas LS, Tajer C, Gil Moreno M, Corvalán R, Isea JE, Romero G, on behalf of the ECLA (Estudios Cardiológicos Latinoamérica) Collaborative Group. Metabolic modulation of acute myocardial infarction. The ECLA Glucose-Insulin-Potassium pilot trial. Circulation 1998;98:2227-2234.
18. World Bank. World Development Indicators Database. Washington DC; 2000.
19. Harrel FE Jr. Regression Modeling Strategies: with Applications to Linear Models, Logistic Regression and Survival Analysis. Springer-Verlag, New York, NY; 2001. p20-24.
20. Lee KL, Woodlief LH, Topol EJ, Douglas WW, Betriu A, Col J, Simoons M, Aylward P, Van de Werf F, Califf R, for the GUSTO-I Investigators. Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction: results from an international trial of 41021 patients. Circulation 1995;91:1659-1668.
21. Allison PD. Logistic Regression Using the SAS® System: Theory and Application. Cary, NC: SAS Institute Inc.; 1999. p51-58.
22. Simes J, White HD, Marschner IC, Varshavsky S, Diaz R, French JK, Aylward P. International differences in patients, care and outcomes associated with acute myocardial infarction (AMI): the HERO-2 trial. J Am Coll Cardiol 2002;39(suppl. B):10B.
23. Boersma E, Maas AC, Deckers JW. Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour. Lancet 1996;348:771-775.
24. Tardiff B, Califf R, Morris D, Bates E, Woodlief L, Lee K, Green C, Rutsch W, Betriu A, Aylward P, Topol E, for the GUSTO Investigators. Coronary revascularization surgery after myocardial infarction: impact of bypass surgery on survival after thrombolysis. J Am Coll Cardiol 1997;29:240-249.
25. Morrow DA, Antman EM, Charlesworth A, Cairns R, Murphy SA, de Lemos JA, Giugliano RP, McCabe CH, Braunwald E. TIMI risk score for ST-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation: an Intravenous nPA for Treatment of Infarcting Myocardium Early II Trial Substudy. Circulation 2000;102:2031-2037.
26. Philippe F, Larrazet F, Dibie A, Bouabdallah K, Carbognani D, Folliguet T, Czitrom D, Lagier A, Laborde F, Cohen A, Montalescot G. Management of acute coronary syndromes in a new French coronary intensive care unit. The first four years of activity in the GRACE registry (Global Registry of Acute Coronary Events). Ann Cardiol Angeiol (Paris) 2005;54:68-73.